results of engot-ov16/nova phase iii trial of niraparib in platinum-sensitive ovarian cancer
Published 7 years ago • 191 plays • Length 2:55Download video MP4
Download video MP3
Similar videos
-
2:26
trial design of engot-ov16/nova phase iii trial of niraparib in platinum-sensitive ovarian cancer
-
3:10
overview of engot-ov16/nova of niraparib in ovarian cancer and why the results were not surprising
-
1:50
niraparib as maintenance for platinum-sensitive ovarian cancer - results from engot-ov16/nova trial
-
2:39
nova phase iii trial of niraparib in platinum-sensitive ovarian cancer patients
-
9:24
results from the engot-ov16/nova trial: efficacy and safety of niraparib in ovarian cancer
-
1:14
next steps for niraparib for ovarian cancer following on from the engot-ov16/nova trial
-
1:13
comparison of trials of niraparib, olaparib and rucaparib in ovarian cancer
-
5:13
treating ovarian cancer with niraparib: the nova trial
-
1:35
dr. mirza on the phase iii nova trial in ovarian cancer
-
3:11
ovarian cancer phase iii trial updates: imagyn050 and icon8
-
1:40
neo trial: neoadjuvant olaparib in platinum-sensitive relapsed high-grade serous ovarian cancer
-
2:17
combination therapy to treat ovarian cancer: promising results from the ananova trial
-
4:34
niraparib in newly diagnosed advanced ovarian cancer: prima results
-
2:25
results of niraparib/bevacizumab combo in platinum-sensitive recurrent ovarian cancer
-
2:11
design of the nova trial for ovarian cancer
-
6:10
ago-ovar 2.29/engot-ov34: atezolizumab vs placebo bevacizumab w/ chemo recurrent ovarian cancer
-
6:57
niraparib maintenance for recurrent ovarian cancer
-
3:09
the promising potential of parp inhibitors in ovarian cancer
-
1:47
dr. matulonis on the nova trial of niraparib maintenance therapy in ovarian cancer